Clinical Trial Update: A Pharmacokinetic (PK) Study of NatrOVA Topical Creme (1%) in Pediatric Subjects 6 to 24 Months of Age [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of NatrOVA Topical Creme 1% in pediatric subjects aged 6 to 24 months to evaluate systemic exposure. The trial addresses pediculos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pediculosis Capitis

Drugs mentioned

• NatrOVA Topical Creme 1%

Snippet

Sponsor: ParaPRO LLC | Conditions: Pediculosis Capitis (Head Lice) | Phase 1 | Status: COMPLETED